首页> 外国专利> PHARMACEUTICAL AGENT FOR PREVENTION AND/OR TREATMENT OF HTLV-I-ASSOCIATED MYELOPATHY

PHARMACEUTICAL AGENT FOR PREVENTION AND/OR TREATMENT OF HTLV-I-ASSOCIATED MYELOPATHY

机译:预防和/或治疗HTLV-I相关性骨髓病的药物代理商

摘要

PROBLEM TO BE SOLVED: To provide a therapeutic agent for HTLV-I-associated diseases such as HTLV-I-associated myelopathy and uveitides.SOLUTION: There is provided a pharmaceutical agent for HTLV-I-associated diseases such as HTLV-I-associated myelopathy and uveitides, comprising, as an active ingredient, an RAR agonist represented by formula (I) [wherein Rto Rindependently represent a hydrogen atom, an alkyl group, or an alkyl-substituted silyl group; X represents -CO-NH-, -NH-CO- or -CO-CH=CH-; and A represents a carboxylate-substituted aromatic group or a tropolonyl group].
机译:要解决的问题:为与HTLV-I相关的疾病,例如HTLV-I相关的脊髓病和葡萄膜炎提供治疗剂。解决方案:提供了与HTLV-I相关的疾病,例如HTLV-I相关的药物。脊髓病和葡萄膜炎,其包含作为活性成分的由式(I)表示的RAR激动剂[其中Rto R独立地表示氢原子,烷基或烷基取代的甲硅烷基; X代表-CO-NH-,-NH-CO-或-CO-CH = CH-; [式中,A表示羧酸根取代的芳香族基或tropolonyl]。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号